Agenesis of the corpus callosum: What to tell expecting parents?
Prenatal Diagnosis · 2023-11 · 43 (12) · 1527-1535
DOI: 10.1002/pd.6447 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Prenatal Diagnosis, online erschienen am 04.10.2023. Verfasst von Pascale Tsai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Michael G. DeGroote School of Medicine, Waterloo Regional Campus, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Corpus Callosum, Nervous System Malformations. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Agenesis of the corpus callosum (ACC) is one of the most common brain malformations, with an incidence estimated to range from 0.5 to 70 in 10,000 among the general population. Prenatal diagnosis is made via ultrasound; however, fetal MRI is useful to confirm or exclude the presence of associated cerebral abnormalities–mostly cortical malformations–that may affect postnatal prognosis. When no additional central nervous system (CNS) or extra CNS anomalies are identified and no genetic cause is found, an isolated ACC is diagnosed. Overall, in cases of ACC, an underlying genetic cause can be identified in up to 12.5% with chromosomal microarray (CMA) and up to 47% with whole exome sequencing (WES). In cases where ACC is the only anomaly detected, the yield of WES is 30%. Postnatal outcomes are variable and depend on whether the condition is isolated or not. In truly isolated ACC, outcomes range from normal in 65% of cases through mild to severe neurodevelopmental impairments in 35% of cases. An interdisciplinary team of medical experts is key in guiding parents toward informed decision‐making in pregnancies complicated by ACC. Considering current and expected advancements in genetic testing and imaging technologies in upcoming years, we herein summarize current recommendations for the management and prenatal counseling of expecting parents of fetuses with ACC. Our review pertains primarily to expecting parents of fetuses with complete ACC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Michael G. DeGroote School of Medicine, Waterloo Regional Campus, McMaster University, Hamilton, Ontario, Canada.
- Fetal Medicine Unit, Ontario Fetal Center, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Pascale Tsai, Shiri Shinar
Zitieren
APA
Tsai, P., & Shinar, S. (2023). Agenesis of the corpus callosum: What to tell expecting parents?. Prenatal Diagnosis, 43(12), 1527-1535. https://doi.org/10.1002/pd.6447
Vancouver
Tsai P, Shinar S. Agenesis of the corpus callosum: What to tell expecting parents?. Prenatal Diagnosis. 2023;43(12):1527-1535. doi:10.1002/pd.6447
BibTeX
@article{Tsai2023,
author = {Tsai, Pascale and Shinar, Shiri},
title = {Agenesis of the corpus callosum: What to tell expecting parents?},
journal = {Prenatal Diagnosis},
year = {2023},
volume = {43},
number = {12},
pages = {1527--1535},
doi = {10.1002/pd.6447}
}
EUVIMED